Cargando…
Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
Platelet activation has been implicated in microvascular thrombosis and organ failure in critically ill patients. In the first part the present paper summarises important data on the role of platelets in systemic inflammation and sepsis as well as on the beneficial effects of antiplatelet drugs in a...
Autores principales: | Lösche, Wolfgang, Boettel, Janina, Kabisch, Björn, Winning, Johannes, Claus, Ralf A., Bauer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216368/ https://www.ncbi.nlm.nih.gov/pubmed/22110915 http://dx.doi.org/10.1155/2012/720254 |
Ejemplares similares
-
Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients
por: Sossdorf, Maik, et al.
Publicado: (2013) -
Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice
por: Winning, J, et al.
Publicado: (2007) -
Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021) -
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis
por: Su, Wanting, et al.
Publicado: (2022) -
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)